sample_id	patient_name	dataset_id	dataset_group	Treatment	response	response_NR	M Stage	overall survival (days)	vital status	Total Mutation	Gender	Therapy	age_start	tumor_type	seq_type	id
4885	CR04885	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	IIIc	766.5	Alive		Female	anti-CTLA-4	49	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
6670	CR06670	Nathanson_2017	Melanoma_Nathanson_2017	POST	R	R	IIIc	1350.5	Dead		Female	anti-CTLA-4	79	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
22640	CR22640	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1c	1569.5	Alive		Male	anti-CTLA-4	71	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
6126	CR6126	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1b	693.5	Alive		Female	anti-CTLA-4	66	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
6161	CR6161	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1b	949.0	Dead		Male	anti-CTLA-4	81	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
244	CRNR0244	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	766.5	Alive		Male	anti-CTLA-4	49	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
2472	CRNR2472	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	620.5	Alive		Male	anti-CTLA-4	71	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4941	CRNR4941	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	2628.0	Alive		Female	anti-CTLA-4	40	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
167	LSD0167	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1c	985.5	Alive		Male	anti-CTLA-4	33	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
2057	LSD2057	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1c	1204.5	Alive		Female	anti-CTLA-4	36	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
3484	LSD3484	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1c	1058.5	Alive		Male	anti-CTLA-4	74	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4691	LSD4691	Nathanson_2017	Melanoma_Nathanson_2017	POST	R	R	M1c	2664.5	Alive		Male	anti-CTLA-4	62	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4744	LSD4744	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1c	766.5	Alive		Male	anti-CTLA-4	52	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
6819	LSD6819	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1c	1241.0	Alive		Male	anti-CTLA-4	55	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
1120	LSDNR1120	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1a	1679.0	Alive		Male	anti-CTLA-4	68	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
1650	LSDNR1650	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	985.5	Dead		Female	anti-CTLA-4	71	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
9298	LSDNR9298	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	1533.0	Alive		Female	anti-CTLA-4	82	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
2137	NR2137	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1c	292.0	Dead		Male	anti-CTLA-4	18	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4018	NR4018	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1C	109.5	Dead		Male	anti-CTLA-4	55	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4045	NR4045	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	620.5	Dead		Male	anti-CTLA-4	42	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4083	NR4083	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1C	73.0	Dead		Male	anti-CTLA-4	54	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4631	NR4631	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	182.5	Dead		Male	anti-CTLA-4	59	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
6689	NR6689	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	438.0	Dead		Female	anti-CTLA-4	46	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
6721	NR6721	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1a	292.0	Dead		Male	anti-CTLA-4	64	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
6842	NR6842	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1c	292.0	Dead		Male	anti-CTLA-4	64	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
8815	NR8815	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1b	438.0	Dead		Female	anti-CTLA-4	67	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
9445	NR9445	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1c	73.0	Dead		Male	anti-CTLA-4	50	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
9449	NR9449	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	219.0	Dead		Female	anti-CTLA-4	64	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
9521	NR9521	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1b	985.5	Dead		Male	anti-CTLA-4	74	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
9705	NR9705	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	438.0	Dead		Female	anti-CTLA-4	63	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
9765	NR9765	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1b	766.5	Dead		Female	anti-CTLA-4	38	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
3803	PR03803	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	IIIc	2883.5	Dead		Male	anti-CTLA-4	90	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
12117	PR12117	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1c	584.0	Dead		Male	anti-CTLA-4	66	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4035	PR4035	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1c	1533.0	Alive		Male	anti-CTLA-4	78	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4046	PR4046	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1a	766.5	Alive		Male	anti-CTLA-4	44	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4077	PR4077	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1c	2226.5	Alive		Male	anti-CTLA-4	75	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4091	PR4091	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1a	2190.0	Alive		Female	anti-CTLA-4	65	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4092	PR4092	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1a	2226.5	Alive		Female	anti-CTLA-4	57	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
3086	LSDNR3086	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	949.0	Dead		Male	anti-CTLA-4	43	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
1509	CR1509	Nathanson_2017	Melanoma_Nathanson_2017	POST	R	R	M1c	1642.5	Alive		Female	anti-CTLA-4	54	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
9306	CR9306	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1c	1934.5	Alive		Male	anti-CTLA-4	65	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
95	CR0095	Nathanson_2017	Melanoma_Nathanson_2017	POST	R	R	M1b	2080.5	Alive		Male	anti-CTLA-4	74	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4880	CR4880	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1b	1971.0	Alive		Male	anti-CTLA-4	63	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
7623	CR7623	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	1460.0	Alive		Male	anti-CTLA-4	62	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
3665	CR3665	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1b	985.5	Alive		Male	anti-CTLA-4	70	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
9699	CR9699	Nathanson_2017	Melanoma_Nathanson_2017	POST	R	R	M1c	1606.0	Alive		Male	anti-CTLA-4	70	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
346	SD0346	Nathanson_2017	Melanoma_Nathanson_2017	POST	R	R	M1b	1058.5	Dead		Female	anti-CTLA-4	43	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
6336	SD6336	Nathanson_2017	Melanoma_Nathanson_2017	POST	R	R	M1c	2518.5	Alive		Male	anti-CTLA-4	53	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
1494	SD1494	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1c	730.0	Alive		Male	anti-CTLA-4	70	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
2056	SD2056	Nathanson_2017	Melanoma_Nathanson_2017	PRE	R	R	M1b	1423.5	Alive		Female	anti-CTLA-4	39	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
2051	SD2051	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1c	292.0	Dead		Female	anti-CTLA-4	61	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
5038	SD5038	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	438.0	Dead		Male	anti-CTLA-4	55	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
5934	SD5934	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	584.0	Dead		Male	anti-CTLA-4	52	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
5118	SD5118	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	985.5	Dead		Female	anti-CTLA-4	55	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
6494	SD6494	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	255.5	Dead		Female	anti-CTLA-4	63	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
7357	SD7357	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	730.0	Dead		Female	anti-CTLA-4	50	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
3156	NR3156	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1b	401.5	Dead		Female	anti-CTLA-4	68	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
5784	NR5784	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1c	182.5	Dead		Female	anti-CTLA-4	58	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
8727	NR8727	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1c	146.0	Dead		Male	anti-CTLA-4	69	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4949	NR4949	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	255.5	Dead		Female	anti-CTLA-4	79	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
1867	NR1867	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1c	547.5	Dead		Male	anti-CTLA-4	68	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
3549	NR3549	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1c	182.5	Dead		Male	anti-CTLA-4	50	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
9341	NR9341	Nathanson_2017	Melanoma_Nathanson_2017	PRE	NR	N	M1a	365.0	Dead		Male	anti-CTLA-4	77	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
4810	NR4810	Nathanson_2017	Melanoma_Nathanson_2017	POST	NR	N	M1c	146.0	Dead		Female	anti-CTLA-4	48	Melanoma	RNA-seq	Melanoma_Nathanson_2017_anti-CTLA-4
